André Chollet

Title: André Chollet: Innovator in Pharmaceutical Chemistry

Introduction

André Chollet is a notable inventor based in Plan-les-Ouates, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues. With a total of 2 patents, Chollet's work is recognized for its potential impact on medical treatments.

Latest Patents

Chollet's latest patents include the crystalline compound Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2'-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime. This patent discloses methods of using the compound for treating conditions related to OT-R activity, such as preterm labor, and for increasing the embryo implantation rate in mammals undergoing embryo transfer. Another patent focuses on a similar crystalline compound, Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2'-methyl-1,1-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, which also addresses the same medical applications.

Career Highlights

Chollet is currently associated with Obseva S.A., a company dedicated to advancing women's reproductive health through innovative therapies. His work at Obseva has positioned him as a key player in the pharmaceutical industry, contributing to the development of groundbreaking treatments.

Collaborations

Chollet collaborates with Olivier Pohl, enhancing the research and development efforts at Obseva. Their partnership exemplifies the importance of teamwork in driving innovation in the pharmaceutical sector.

Conclusion

André Chollet's contributions to pharmaceutical chemistry through his patents and work at Obseva S.A. highlight his commitment to improving health outcomes. His innovative approaches to addressing critical medical conditions demonstrate the vital role of inventors in advancing healthcare solutions.